Search research articles
Contact Us
Filters
Showing results (11-20 of 192) with videos related to
Page
of 20
Sort By:
Journal of Biopharmaceutical Statistics
|
March 22, 2024
Analysis of innovative two-stage seamless adaptive design with different endpoints and population shift
Weijia Mai, Shein-Chung Chow
Journal of Biopharmaceutical Statistics
|
August 28, 2019
The use of 95% CI or 90% CI for drug product development - a controversial issue?
Shein-Chung Chow, Jiayin Zheng
Journal of Biopharmaceutical Statistics
|
September 10, 2019
Criteria for dose-finding in two-stage seamless adaptive design
Jiayin Zheng, Shein-Chung Chow
Journal of Biopharmaceutical Statistics
|
November 9, 2010
On flexibility of adaptive designs and criteria for choosing a good one--a discussion of FDA draft guidance
Bin Cheng, Shein-Chung Chow
Pharmaceutical Statistics
|
November 25, 2010
Assessing departure from dose linearity under a repeated measures incomplete block design
Bin Cheng, Shein-Chung Chow
Journal of Biopharmaceutical Statistics
|
December 10, 2016
Assessing bioequivalence and drug interchangeability
Meng Chen, Shein-Chung Chow
Journal of Biopharmaceutical Statistics
|
January 5, 2017
On the establishment of equivalence acceptance criterion in analytical similarity assessment
Tongrong Wang, Shein-Chung Chow
Journal of Biopharmaceutical Statistics
|
August 19, 2003
Stability analysis with discrete responses
Shein-Chung Chow, Jun Shao
Statistics in Medicine
|
August 7, 2025
A Statistical Method for Benefit-Risk Assessment in Clinical Trials
Yinuo Zhang, Shein-Chung Chow
Therapeutic Innovation & Regulatory Science
|
April 8, 2025
Development of Composite Index in Psychiatry Clinical Trial
Haiqi Zhang, Shein-Chung Chow
Page
of 20
Search research articles
Search
Showing results (11-20 of 192) with videos related to
Sort By:
Page
of 20
Journal of Biopharmaceutical Statistics
|
March 22, 2024
Analysis of innovative two-stage seamless adaptive design with different endpoints and population shift
Weijia Mai, Shein-Chung Chow
Journal of Biopharmaceutical Statistics
|
August 28, 2019
The use of 95% CI or 90% CI for drug product development - a controversial issue?
Shein-Chung Chow, Jiayin Zheng
Journal of Biopharmaceutical Statistics
|
September 10, 2019
Criteria for dose-finding in two-stage seamless adaptive design
Jiayin Zheng, Shein-Chung Chow
Journal of Biopharmaceutical Statistics
|
November 9, 2010
On flexibility of adaptive designs and criteria for choosing a good one--a discussion of FDA draft guidance
Bin Cheng, Shein-Chung Chow
Pharmaceutical Statistics
|
November 25, 2010
Assessing departure from dose linearity under a repeated measures incomplete block design
Bin Cheng, Shein-Chung Chow
Journal of Biopharmaceutical Statistics
|
December 10, 2016
Assessing bioequivalence and drug interchangeability
Meng Chen, Shein-Chung Chow
Journal of Biopharmaceutical Statistics
|
January 5, 2017
On the establishment of equivalence acceptance criterion in analytical similarity assessment
Tongrong Wang, Shein-Chung Chow
Journal of Biopharmaceutical Statistics
|
August 19, 2003
Stability analysis with discrete responses
Shein-Chung Chow, Jun Shao
Statistics in Medicine
|
August 7, 2025
A Statistical Method for Benefit-Risk Assessment in Clinical Trials
Yinuo Zhang, Shein-Chung Chow
Therapeutic Innovation & Regulatory Science
|
April 8, 2025
Development of Composite Index in Psychiatry Clinical Trial
Haiqi Zhang, Shein-Chung Chow
Page
of 20